Condition
Obesity, Abdominal clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Obesity, Abdominal clinical trials that are recruiting, at sites in 15 countries (most in United States (3), Japan (2), Finland (1)). 1 was first registered in the last 30 days. By phase: Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 15Countries
Newest Obesity, Abdominal clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome | — | Nowy Targ, Lesser Poland Voivodeship | Recruiting | Nov 4, 2026 |
| Orforglipron in adults with overweight at risk for obesity-related problems | Phase 3 | Anniston, Alabama and 179 other locations | Recruiting | Aug 31, 2026 |
| Understanding Circadian Rhythms in Human Fat Tissue | — | Rochester, Minnesota | Recruiting | Mar 24, 2025 |
| Investigating body fat distribution and its impact on metabolic diseases in Japanese adults | — | Sakai, Osaka | Recruiting | Nov 19, 2024 |
| NAD+ therapy to boost brown fat metabolism in adults | — | Turku | Recruiting | Oct 4, 2024 |
| Evaluating Cholestyramine's Effect on Obese Women Before Bariatric Surgery | — | Nice, Alpes-Mritimes | Recruiting | Aug 1, 2023 |
| Effects of menopause and aging on weight gain and fat distribution | Phase 4 | Aurora, Colorado | Recruiting | Aug 2, 2019 |
All recruiting trials (7)
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Orforglipron in adults with overweight at risk for obesity-related problems
This study tests whether orforglipron can help people who are overweight and have early signs of metabolic or cardiovascular risk.
-
Understanding Circadian Rhythms in Human Fat Tissue
This study is testing how different eating patterns affect the natural body clock of fat cells in people with and without obesity.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
NAD+ therapy to boost brown fat metabolism in adults
This trial will test whether giving an NAD+ precursor to sedentary adults aged 30–55 can boost brown fat activity and improve insulin sensitivity in both normal-weight and centrally obese people.
-
Evaluating Cholestyramine's Effect on Obese Women Before Bariatric Surgery
This study is testing if a medication called cholestyramine can help reduce harmful chemicals in the bodies of obese women before they have weight loss surgery.
-
Effects of menopause and aging on weight gain and fat distribution
This study is testing how menopause affects weight gain and belly fat in women by looking at hormones and seeing if adjusting these hormones can help reduce fat.
Related topics
Quick answers
How many Obesity, Abdominal clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in United States (3 trials), Japan (2 trials), Finland (1 trial), Poland (1 trial), Argentina (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.